Clinical Trial Update: A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Of AJ201 In Patients [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial evaluating safety, tolerability, PK, and PD of AJ201 in patients with spinal and bulbar muscular atrophy (Kennedy's disease) has completed Phas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kennedy Disease
• Spinal and Bulbar Muscular Atrophy

Drugs mentioned

• AJ201

Snippet

Sponsor: AnnJi Pharmaceutical Co., Ltd. | Conditions: Spinal and Bulbar Muscular Atrophy, Kennedy's Disease | Phase 1, Phase 2 | Status: COMPLETED